Departamento de Biología Funcional, Universidad de Oviedo, Oviedo, Asturias, Spain.
Instituto Universitario de Oncología del Principado de Asturias (IUOPA), Universidad de Oviedo, Oviedo, Asturias, Spain.
Appl Environ Microbiol. 2018 Aug 31;84(18). doi: 10.1128/AEM.01462-18. Print 2018 Sep 15.
Macrolactams comprise a family of natural compounds with important bioactivities, such as antibiotic, antifungal, and antiproliferative activities. Sipanmycins A and B are two novel members of this family, with two sugar moieties attached to the aglycon. In the related macrolactam vicenistatin, the sugar moiety has been proven to be essential for cytotoxicity. In this work, the gene cluster responsible for the biosynthesis of sipanmycins ( cluster) in sp. strain CS149 is described and the steps involved in the glycosylation of the final compounds unraveled. Also, the cooperation of two different glycosyltransferases in each glycosylation step is demonstrated. Additionally, the essential role of SipO2 as an auxiliary protein in the incorporation of the second deoxy sugar is addressed. In light of the results obtained by the generation of mutant strains and characterization of the cluster, a biosynthetic pathway for sipanmycins and the two deoxy sugars attached is proposed. Finally, the importance of the hydroxyl group at C-10 of the macrolactam ring and the sugar moieties for cytotoxicity and antibiotic activity of sipanmycins is shown. The rapid emergence of infectious diseases and multiresistant pathogens has increased the necessity for new bioactive compounds; thus, novel strategies have to be developed to find them. Actinomycetes isolated in symbiosis with insects have attracted attention in recent years as producers of metabolites with important bioactivities. Sipanmycins are glycosylated macrolactams produced by sp. CS149, isolated from leaf-cutting ants, and show potent cytotoxic activity. Here, we characterize the cluster and propose a biosynthetic pathway for sipanmycins. As far as we know, it is the first time that the cooperation between two different glycosyltransferases is demonstrated to be strictly necessary for the incorporation of the same sugar. Also, a third protein with homology to P450 monooxygenases, SipO2, is shown to be essential in the second glycosylation step, forming a complex with the glycosyltransferase pair SipS9-SipS14.
大环内酯类化合物是一类具有重要生物活性的天然化合物,如抗生素、抗真菌和抗增殖活性。Sipanmycins A 和 B 是该家族的两个新成员,其糖苷配基上连接有两个糖基。在相关的大环内酯类 vicenistatin 中,已证明糖基对于细胞毒性是必不可少的。在这项工作中,描述了 sp. CS149 中负责 sipanmycins 生物合成的基因簇( cluster ),并揭示了最终化合物糖基化涉及的步骤。还证明了每个糖基化步骤中两种不同糖基转移酶的合作。此外,还解决了 SipO2 作为辅助蛋白在第二个脱氧糖掺入中的重要作用。鉴于通过生成突变株获得的结果和 cluster 的特征,提出了 sipanmycins 和连接的两个脱氧糖的生物合成途径。最后,表明大环内酯环上 C-10 位的羟基和糖基对于 sipanmycins 的细胞毒性和抗生素活性的重要性。传染病和多耐药病原体的迅速出现增加了对新生物活性化合物的需求;因此,必须开发新的策略来寻找它们。近年来,与昆虫共生的放线菌作为具有重要生物活性的代谢产物的生产者引起了人们的关注。Sipanmycins 是由 sp. CS149 产生的糖基化大环内酯类化合物,从切叶蚁中分离出来,具有很强的细胞毒性。在这里,我们对 cluster 进行了表征,并提出了 sipanmycins 的生物合成途径。据我们所知,这是首次证明两种不同糖基转移酶的合作对于同一糖的掺入是严格必需的。此外,还证明了具有 P450 单加氧酶同源性的第三个蛋白 SipO2 在第二个糖基化步骤中是必不可少的,它与糖基转移酶对 SipS9-SipS14 形成复合物。